Due to mergers and acquisitions, laboratory downsizing or upgrading, or outsourcing, many biopharmaceutical companies are opting to sell R&D or manufacturing equipment that they no longer need but are still in good working condition. Mainstream adoption of buying and selling used biopharmaceutical equipment has created an economical way for organizations to make and save money through the resale of surplus assets. In fact, more companies are taking a proactive approach in managing their surplus, causing a consistent year-over-year increase in the volume of inventory available on the secondary marketplace.
© 2024 Liquidity Services, Inc. | Supplier Code of Conduct | Privacy Policy |
Comments are closed.